CTOR - Citius Oncology
CTOR is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.
Is anyone targeting this fund?
Not right now - Wolverine was in this company until Sept 5, 2024 and has since sold down.
What this means for you
Wolverine owned more than 5% of this company and has since sold down below that level, so it no longer has to report its holding.
Nothing is required of you. If a large investor buys in again, the notice appears here the day it is filed.
What happened, and when
-
Sept 5, 2024
Wolverine sold down below 5% and stopped reporting.
Original document → -
March 7, 2024
Karpus sold down below 5% and stopped reporting.
Original document → -
Feb 13, 2024
Karpus now owns 5.6%, as a passive investor.
Original document → -
Feb 8, 2024
Wolverine now owns 6.3%, as a passive investor.
Original document →
Details: all notices, events and fund facts
| Date | Investor | Stake | Type of notice |
|---|---|---|---|
| Sept 5, 2024 | Wolverine | 0% | Sold down below 5% |
| March 7, 2024 | Karpus | 0% | Sold down below 5% |
| Feb 13, 2024 | Karpus | 5.6% | Passive investor |
| Feb 8, 2024 | Wolverine | 6.3% | Passive investor |
No announcements from the fund on file.
- Run by
- not filed yet
- Fund family
- not filed yet
- Exchange
- Nasdaq
Email me when something new is filed for CTOR
Free. One email per notice or announcement, usually within a day. No password.